Justin Walsh

Stock Analyst at Jones Trading

(0)
# 3755
Out of 5,243 analysts
38
Total ratings
34.62%
Success rate
-0.38%
Average return
22 Stocks
Name Action Price Target Current % Upside Ratings Updated
Alto Neuroscience
Initiates Coverage On: Buy
18
4.51 299.11% 1 Dec 16, 2024
Rapport Therapeutics
Initiates Coverage On: Buy
42
13.37 214.14% 1 Oct 18, 2024
Theratechnologies
Downgrades: Hold
n/a
n/a n/a 2 Oct 11, 2024
BioLine Rx
Initiates Coverage On: Buy
2
0.11 1718.18% 1 Sep 4, 2024
Lantheus Holdings
Maintains: Strong Buy
105 146
93.69 55.83% 7 Jul 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
6.47 255.49% 1 Jul 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
15 22
3.27 572.78% 2 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
4.62 246.32% 1 May 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
3.24 517.28% 1 Apr 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Mar 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
4
1.08 270.37% 4 Sep 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
2.78 619.42% 1 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
1.32 1263.64% 2 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 1
n/a n/a 2 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
175
n/a n/a 1 Mar 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
440
5.46 7958.61% 1 Feb 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
75
1.19 6202.52% 1 Oct 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 20
34.21 -41.54% 1 May 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
440 200
3.25 6053.85% 2 Apr 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
2.21 352.49% 1 Jan 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
800
4.08 19507.84% 1 Sep 2, 2021